AII
BMY.RT

AGF Investments Inc’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

AGF Investments Inc’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,895
Closed -$3K – 787
2020
Q4 		$3K Hold
4,895
– – ﹤0.01% 700
2020
Q3 		$11K Hold
4,895
– – ﹤0.01% 706
2020
Q2 		$18K Hold
4,895
– – ﹤0.01% 693
2020
Q1 		$19K Buy
+4,895
New +$16.1K ﹤0.01% 689

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

AGF Investments Inc's BMY.RT Position: Q1 2021 in Review

AGF Investments Inc sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 4,895 shares — an estimated $3K sold.

AGF Investments Inc first reported a position in BMY.RT in Q1 2020 and held it in 4 quarters. The position peaked at $19K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • AGF Investments Inc reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • AGF Investments Inc sold 4,895 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $3K.
  • AGF Investments Inc first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2020 and held it in 4 quarters.
  • AGF Investments Inc's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $19K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on AGF Investments Inc's 13F filing for Q1 2021, filed 14 May 2021.